Sendzik; Martin

Patent Applications and Registrations

Patent applications and USPTO patent grants for Sendzik; Martin.The latest application filed is for "n-azaspirocycloalkane substituted n-heteroaryl compounds and compositions for inhibiting the activity of shp2".

Company Profile

16.44.61

Sendzik; Martin - Belmont MA
Sendzik; Martin - San Mateo CA
Sendzik; Martin - US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
N-azaspirocycloalkane Substituted N-heteroaryl Compounds And Compositions For Inhibiting The Activity Of Shp2 App 20220073537 - Chen; Christine Hiu-Tung ; et al.	2022-03-10
Triazolopyrimidine compounds and uses thereof Grant 11,207,325 - Chan , et al. December 28, 2	2021-12-28
N-azaspirocycloalkane Substituted N-heteroaryl Compounds And Compositions For Inhibiting The Activity Of Shp2 App 20210371429 - Chen; Christine Hiu-Tung ; et al.	2021-12-02
Compounds And Compositions For Inhibiting The Activity Of Shp2 App 20210300919 - CHEN; Zhuoliang ; et al.	2021-09-30
N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2 Grant 10,968,235 - Chen , et al. April 6, 2	2021-04-06
Compounds and compositions for inhibiting the activity of SHP2 Grant 10,934,285 - Chen , et al. March 2, 2	2021-03-02
Triazolopyrimidine Compounds And Uses Thereof App 20200323859 - CHAN; Ho Man ; et al.	2020-10-15
Triazolopyridine compounds and uses thereof Grant 10,689,378 - Chan , et al.	2020-06-23
N-azaspirocycloalkane Substituted N-heteroaryl Compounds And Compositions For Inhibiting The Activity Of Shp2 App 20200181168 - Chen; Christine Hiu-Tung ; et al.	2020-06-11
Imidazolepyridine compounds and uses thereof Grant 10,676,479 - Chan , et al.	2020-06-09
Compounds And Compositions For Inhibiting The Activity Of Shp2 App 20200002330 - CHEN; Zhuoliang ; et al.	2020-01-02
Imidazolepyridine Compounds And Uses Thereof App 20190233426 - CHAN; Ho Man ; et al.	2019-08-01
Triazolopyridine Compounds And Uses Thereof App 20190202828 - CHAN; Ho Man ; et al.	2019-07-04
N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2 Grant 10,336,774 - Chen , et al.	2019-07-02
Compounds and compositions for inhibiting the activity of SHP2 Grant 10,308,660 - Chen , et al.	2019-06-04
1-(triazin-3-yl/pyridazin-3-yl)-piper(-azine)idine derivatives and compositions therefor for inhibiting the activity of SHP2 Grant 10,301,278 - Chen , et al.	2019-05-28
Triazolopyrimidine Compounds And Uses Thereof App 20190142837 - CHAN; Ho Man ; et al.	2019-05-16
Compounds and compositions for inhibiting the activity of SHP2 Grant 10,287,266 - Chen , et al.	2019-05-14
Triazolopyrimidine compounds and uses thereof Grant 10,220,036 - Chan , et al.	2019-03-05
Compounds and compositions as RAF kinase inhibitors Grant 10,167,279 - Aversa , et al. J	2019-01-01
3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH Grant 10,112,931 - Caferro , et al. October 30, 2	2018-10-30
N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2 Grant 10,077,276 - Chen , et al. September 18, 2	2018-09-18
Compounds And Compositions For Inhibiting The Activity Of Shp2 App 20180251471 - Chen; Zhuoliang ; et al.	2018-09-06
N-azaspirocycloalkane Substituted N-heteroaryl Compounds And Compositions For Inhibiting The Activity Of Shp2 App 20180201623 - Chen; Christine Hiu-Tung ; et al.	2018-07-19
Compounds And Compositions For Inhibiting The Activity Of Shp2 App 20180186770 - Chen; Zhuoliang ; et al.	2018-07-05
Compounds And Compositions As Raf Kinase Inhibitors App 20180170917 - AVERSA; Robert John ; et al.	2018-06-21
1-(triazin-3-yl/pyridazin-3-yl)-piper(-azine)idine Derivatives And Compositions Therefor For Inhibiting The Activity Of Shp2 App 20180065949 - Chen; Zhuoliang ; et al.	2018-03-08
3-pyrimidin-4-yl-oxazolidin-2-ones As Inhibitors Of Mutant Idh App 20180051015 - CAFERRO; Thomas Raymond ; et al.	2018-02-22
Triazolopyrimidine Compounds And Uses Thereof App 20170348312 - CHAN; Ho Man ; et al.	2017-12-07
1-(triazin-3-yl/pyridazin-3-yl)-piper(-azine)idine derivatives and compositions therefor for inhibiting the activity of SHP2 Grant 9,815,813 - Chen , et al. November 14, 2	2017-11-14
3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH Grant 9,688,672 - Caferro , et al. June 27, 2	2017-06-27
Triazolopyrimidine compounds and uses thereof Grant 9,580,437 - Chan , et al. February 28, 2	2017-02-28
N-azaspirocycloalkane Substituted N-heteroaryl Compounds And Compositions For Inhibiting The Activity Of Shp2 App 20170015680 - Chen; Christine Hiu-Tung ; et al.	2017-01-19
1-(triazin-3-yl/pyridazin-3-yl)-piper(-azine)idine Derivatives And Compositions Therefor For Inhibiting The Activity Of Shp2 App 20170001975 - Chen; Zhuoliang ; et al.	2017-01-05
3-pyrimidin-4-yl-oxazolidin-2-ones As Inhibitors Of Mutant Idh App 20160318915 - CAFERRO; Thomas Raymond ; et al.	2016-11-03
3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH Grant 9,434,719 - Caferro , et al. September 6, 2	2016-09-06
Triazolopyrimidine Compounds And Uses Thereof App 20160176882 - CHAN; Ho Man ; et al.	2016-06-23
Hydroxamates as therapeutic agents Grant 9,186,347 - Verner , et al. November 17, 2	2015-11-17
Novel Hydroxamates As Therapeutic Agents App 20150320718 - VERNER; Erik J. ; et al.	2015-11-12
3-pyrimidin-4-yl-oxazolidin-2-ones As Inhibitors Of Mutant Idh App 20150152093 - Caferro; Thomas Raymond ; et al.	2015-06-04
3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH Grant 8,957,068 - Caferro , et al. February 17, 2	2015-02-17
Heterocyclic compounds and uses thereof Grant 8,865,732 - Huang , et al. October 21, 2	2014-10-21
Novel Hydroxamates As Therapeutic Agents App 20140301976 - VERNER; Erik J. ; et al.	2014-10-09
Heteroaryl Compounds And Their Uses App 20140288076 - Barsanti; Paul A. ; et al.	2014-09-25
3-pyrimidin-4-yl-oxazolidin-2-ones As Inhibitors Of Mutant Idh App 20140275083 - CAFERRO; Thomas Raymond ; et al.	2014-09-18
3-pyrimidin-4-yl-oxazolidin-2-ones As Inhibitors Of Mutant Idh App 20140235620 - Caferro; Thomas Raymond ; et al.	2014-08-21
Hydroxamates as therapeutic agents Grant 8,779,171 - Verner , et al. July 15, 2	2014-07-15
Heteroaryl compounds and their uses Grant 8,778,951 - Barsanti , et al. July 15, 2	2014-07-15
6-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signaling Grant 8,710,048 - Sutton , et al. April 29, 2	2014-04-29
3-(aminoaryl)-pyridine Compounds App 20130324530 - Antonios-McCrea; William R. ; et al.	2013-12-05
Substituted Hetero-biaryl Compounds And Their Uses App 20130303507 - Antonios-McCrea; William R. ; et al.	2013-11-14
Novel Heterocyclic Compounds and Uses Thereof App 20130210818 - Huang; Zilin ; et al.	2013-08-15
Heteroaryl Compounds And Their Uses App 20130172354 - Barsanti; Paul A. ; et al.	2013-07-04
Novel Hydroxamates As Therapeutic Agents App 20130142758 - VERNER; Erik J. ; et al.	2013-06-06
Heteroaryl compounds and their uses Grant 8,415,381 - Barsanti , et al. April 9, 2	2013-04-09
Hydroxamates as therapeutic agents Grant 8,389,570 - Verner , et al. March 5, 2	2013-03-05
CSF-1R inhibitors, compositions, and methods of use Grant 8,293,769 - Ng , et al. October 23, 2	2012-10-23
6-O-Substituted Benzoxazole and Benzothiazole Compounds and Methods of Inhibiting CSF-1R Signaling App 20120225861 - Sutton; James C. ; et al.	2012-09-06
Pyrazinylpyridines Useful For The Treatment Of Proliferative Diseases App 20120165306 - Barsanti; Paul A. ; et al.	2012-06-28
Heteroaryl Compounds as Kinase Inhibitors App 20120157433 - Pfister; Keith B. ; et al.	2012-06-21
Compounds and compositions as protein kinase inhibitors Grant 8,202,876 - Albaugh , et al. June 19, 2	2012-06-19
Novel Hydroxamates As Therapeutic Agents App 20120064032 - Verner; Erik J. ; et al.	2012-03-15
Heteroaryl-substituted imidazole compounds and uses thereof Grant 8,129,394 - Hunag , et al. March 6, 2	2012-03-06
Hydroxamates as therapeutic agents Grant 8,026,371 - Verner , et al. September 27, 2	2011-09-27
Heteroaryl Kinase Inhibitors App 20110130380 - Barsanti; Paul A. ; et al.	2011-06-02
Heteroaryl Compounds and Their Uses App 20110028492 - Barsanti; Paul A. ; et al.	2011-02-03
Novel Hydroxamates As Therapeutic Agents App 20110021528 - Verner; Erik J. ; et al.	2011-01-27
6-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signaling App 20100280006 - Sutton; James C. ; et al.	2010-11-04
CSF-1R, Inhibitors, Compositions, and Methods of Use App 20100261679 - Sutton; James ; et al.	2010-10-14
Csf-1r Inhibitors,compositions, And Methods Of Use App 20100130490 - Ng; Simon C. ; et al.	2010-05-27
Compounds And Compositions As Protein Kinase Inhibitors App 20100029605 - Albaugh; Pamela ; et al.	2010-02-04
Novel heterocyclic compounds and uses therof App 20100003246 - Hunag; Zilin ; et al.	2010-01-07
6-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signaling Grant 7,553,854 - Sutton , et al. June 30, 2	2009-06-30
Hydroxamates as therapeutic agents Grant 7,420,089 - Verner , et al. September 2, 2	2008-09-02
Acetylene Derivatives As Inhibitors Of Histone Deacetylase App 20080139547 - SENDZIK; Martin	2008-06-12
Acetylene derivatives as inhibitors of histone deacetylase Grant 7,368,572 - Sendzik May 6, 2	2008-05-06
6-o-substituted Benzoxazole And Benzothiazole Compounds And Methods Of Inhibiting Csf-1r Signaling App 20080045528 - Sutton; JamesC ; et al.	2008-02-21
Novel Hydroxamates As Therapeutic Agents App 20080004331 - Verner; Erik J. ; et al.	2008-01-03
Novel Hydroxamates As Therapeutic Agents App 20070293540 - Verner; Erik J. ; et al.	2007-12-20
Hydroxamates as therapeutic agents Grant 7,276,612 - Verner , et al. October 2, 2	2007-10-02
Novel hydroxamates as therapeutic agents App 20050187261 - Verner, Erik J. ; et al.	2005-08-25
Acetylene derivatives as inhibitors of histone deacetylase App 20050131018 - Sendzik, Martin	2005-06-16
Substituted 1, 4-thiazepine and analogs as activators of caspases and inducers of apoptosis and the use thereof Grant 6,861,419 - Drewe , et al. March 1, 2	2005-03-01